Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma

BACKGROUND: A standard-of-care for locally advanced esophageal and gastroesophageal junction (GEJ) adenocarcinoma is pre-operative chemoradiation. Elevated levels of vascular endothelial growth factor (VEGF) have been associated with worse outcomes following chemoradiation and anti-VEGF therapies ca...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gastrointest Oncol
Autori principali: Ku, Geoffrey Y., Bains, Manjit S., Park, Do Joong, Janjigian, Yelena Y., Rusch, Valerie W., Rizk, Nabil P., Yoon, Sam S., Millang, Brittanie, Capanu, Marinela, Goodman, Karyn A., Ilson, David H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5177593/
https://ncbi.nlm.nih.gov/pubmed/28078107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.08.09
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi